Dr. Mark Larché
Divisions of Clinical Immunology & Allergy, and Respirology,
Department of Medicine and Firestone Institute for Respiratory Health,
The Research Institute at St. Joe’s,
Dr. Larché completed his PhD in Immunology at the Royal Postgraduate Medical School, University of London in 1990. He spent 3 years at St. Jude Children’s Research Hospital, Memphis, TN as a postdoctoral fellow. He returned to the Immunology Department at St. Mary’s Hospital Medical School, prior to joining the faculty of the National Heart and Lung Institute, Imperial College London (1995). In Sept 2006 he moved to McMaster University,Canada.
Dr. Larché has authored over 160 scientific papers and 17 patents. He has been the recipient of several international prizes including “The Respiratory 2000 International Young Investigator Award”, “The Henning Lowenstein Research Award 2000” and the "Pharmacia Allergy Research Foundation Award" in 2001. Together with Professor AB Kay, he co-founded Circassia Ltd. (www.circassia.co.uk ), a biotechnology company developing vaccines for allergic diseases. More recently he was Founding Scientist of Adiga Life Sciences, a Joint Venture between Circassia Ltd and McMaster University. Research interests include the immunopathogenesis of asthma/allergy, immunological mechanisms of immunotherapy, pathogenesis of autoimmune diseases and graft rejection.
Dr. Larché’s research program is funded by CIHR, Canada Research Chairs Program, Canada Foundation for Innovation, Ontario Research Fund, National Institutes of Health (USA), Public Health Agency of Canada, Scleroderma Society of Ontario, McMaster University/GSK endowed Chair and Adiga Life Sciences.
Visit his website for more information.
Dr. Rebecca Richards-Kortum
Malcolm Gillis University Professor
Director, Rice 360 Institute for Global Health
Department of Bioengineering at Rice University
University of Texas Health Science Center
McGovern Medical School
Rebecca Richards-Kortum is the Malcolm Gillis University Professor and a member of the Department of Bioengineering at Rice University. She is also Director of the Rice 360° Institute for Global Health and serves as the special advisor to the Provost on health-related research and educational initiatives.
Dr. Richards-Kortum’s research has been instrumental in improving early detection of cancers and other diseases, especially in low-resource settings. Her Optical Spectroscopy and Imaging Laboratory integrates advances in nanotechnology and molecular imaging with microfabrication technologies to develop optical imaging systems that are inexpensive, portable, and provide point-of-care diagnosis. Her research has led to the development of 40 patents. She is author of the textbook Biomedical Engineering for Global Health, more than 230 refereed research papers, and 11 book chapters. She is a member of numerous academic associations, including the National Academy of Sciences, the National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. In 2016, the American Institute for Medical and Biomedical Engineering (AIMBE) presented its highest honor, the Pierre Galletti Award, to Dr. Richards-Kortum and the MacArthur Foundation awarded her one of its esteemed fellowships. In 2008, she was named a Howard Hughes Medical Institute Professor and subsequently received a grant for the undergraduate global health program at Rice. This program won the Science Prize for Inquiry-Based Instruction from Science magazine and the Lemelson-MIT Award for Global Innovation.
Dr. Luis Barreiro
University of Chicago
Luis Barreiro received his undergraduate and Master’s degrees in Biotechnology at Lusófona University, Lisbon, Portugal. In 2008, he obtained his PhD in Human Population Genetics from the University of Paris VII, followed by a post-doc in the Department of Human Genetics at the University of Chicago. From 2011 to 2018 he was Professor at the Université de Montréal, and a researcher at the CHU Sainte-Justine. He is currently an Associate Professor in the Genetics division, at the University of Chicago. His work has been pioneer at using population genomic data to characterize the genetic basis of inter-individual differences in immune response to infectious agents. Visit his website for more information.
Dr. Nicolas Chomont
Associate research professor,
Centre de Recherche du CHUM,
Dr. Nicolas Chomont is an Associate professor in the Department of Microbiology and Immunology at the Université de Montréal – CHUM Research Center. He obtained his PhD in medical virology at Pierre et Marie Curie University in Paris where he extensively studied the interactions between HIV and the genital mucosa. From 2004 to 2009, he joined Dr Sekaly’s team at the University of Montreal for his post-doctoral training. During this time, he described several cellular reservoirs that contribute to the persistence of HIV in infected individuals receiving antiretroviral therapy. He pursued his research as a principal investigator at the Vaccine & Gene Therapy Institute of Florida to characterize these reservoirs which represent the main obstacle to HIV eradication. At the Université de Montréal, Dr. Chomont is overseeing studies to unravel the molecular mechanisms involved in HIV latency and to develop novel therapeutic strategies aimed at reducing the size of the HIV reservoir.